1.Therapeutic Angiogenesis for Treatment of Ischemic Diseases.
Duk Kyung KIM ; Hyeon Cheol GWON
Journal of Korean Society of Endocrinology 2001;16(3):328-338
No abstract available.
2.A case of choleasteatoma of the frontal sinus.
Sang Hyeon KIM ; Sang Cheol LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(1):178-183
No abstract available.
Frontal Sinus*
3.Viability of preserved Cryptosporidium baileyi oocysts.
Chan Gu SURL ; Se Min KIM ; Hyeon Cheol KIM
The Korean Journal of Parasitology 2003;41(4):197-201
The present study was undertaken to determine the viability and infectivity of oocysts of Cryptosporidium baileyi that had been stored from 1 to 40 months at 4 degrees C preserved in 2.5% potassium dichromate solution. Oocysts of C. baileyi were purified from the feces of experimentally infected chickens using discontinuous sucrose gradients. Subsequently, the purified oocysts were suspended in 2.5% potassium dichromate solution at a concentration of 1 x 10 (7) organism/ml, and their viabilities were assessed by nucleic acid staining, histologic examination, and infectivity to 2-day-old chickens. All chickens inoculated with oocysts that had been stored for 1-18 months developed patent infections, while chickens infected with older oocysts remained uninfected. Between 5.8% and 82.2% of the oocysts, stored at 4 degrees C in 2.5% potassium dichromate solution, were found to be viable, as determined by nucleic acid staining. Parasite colonization in the bursa of Fabricius was detected in the microvillus border of bursal epithelium. The finding that C. baileyi oocysts remain infective to chickens for at least 18 months offers important time-saving advantages to investigators who frequently require large numbers of oocysts.
Animals
;
Bursa of Fabricius/parasitology
;
Chickens/*parasitology
;
Coloring Agents
;
Cryptosporidiosis/parasitology/pathology/*veterinary
;
Cryptosporidium/drug effects/*growth & development/pathogenicity
;
Feces/parasitology
;
Oocysts/drug effects/*growth & development/pathogenicity
;
*Organic Chemicals
;
*Potassium Dichromate/pharmacology
;
Poultry Diseases/parasitology/pathology
;
Preservation, Biological/*methods
;
Staining and Labeling
4.8 cases of delayed endolymphatic hydrops.
Sang Cheol LEE ; Sang Hyeon KIM ; Chun Kun PARK
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(2):226-234
No abstract available.
Endolymphatic Hydrops*
5.Druggable Targets of Squamous Cell Lung Cancer.
Tuberculosis and Respiratory Diseases 2013;75(6):231-235
Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.
Adenocarcinoma
;
Carcinoma, Non-Small-Cell Lung
;
Carcinoma, Squamous Cell
;
Lung Neoplasms*
;
Lung*
6.Molecular Epidemiology of Fecal Oxalobacter formigenes in Healthy Adults Living in Seoul, Using a Polymerase Chain Reaction-Based Detection System.
Byong Chang JUNG ; Cheol KWAK ; Hee Kyung KIM ; Eui Chong KIM ; Hyeon Hoe KIM
Korean Journal of Urology 2000;41(12):1540-1545
No abstract available.
Adult*
;
Humans
;
Molecular Epidemiology*
;
Oxalobacter formigenes*
;
Seoul*
8.Chronic necrotizing pulmonary aspergillosis in a patient with liver cirrhosis.
Hyeon Tae KIM ; Cheol Hyeon KIM ; Jae Cheol LEE
Korean Journal of Medicine 2007;73(3):346-348
No abstract available.
Aspergillosis
;
Humans
;
Invasive Pulmonary Aspergillosis*
;
Liver Cirrhosis*
;
Liver*
9.A clinical review of intussusception.
Pyeong Rang CHOO ; Sun Jin KIM ; Hyeon Suk KIM ; Ho Cheol SHIN ; Eun Sook PARK
Journal of the Korean Academy of Family Medicine 1991;12(6):10-20
No abstract available.
Intussusception*
10.Mechanism of FHIT-Induced Apoptosis in Lung Cancer Cell Lines.
Jung Sun YOO ; Cheol Hyeon KIM
Tuberculosis and Respiratory Diseases 2004;56(5):450-464
BACKGROUND: The FHIT (fragile histidine triad) gene is a frequent target of deletions associated with abnormal RNA and protein expression in lung cancer. Previous studies have shown FHIT gene transfer into lung cancer cell line lacking FHIT protein expression resulted in inhibition of tumor cell growth attributable to the induction of apoptosis and reversion of tumorigenecity. However, the mechanism of the tumor suppressor activity of the FHIT gene and the cellular pathways associated with its function are not completely understood. METHODS: To gain insight into the biological function of FHIT, we compared the NCI-H358 cell line with its stable FHIT transfectants after treatment with cisplatin or paclitaxel. We investigated the effects of FHIT gene expression on cell proliferation, apoptosis, and activation of caspase system and Bcl-2 family. The induction of apoptosis was evaluated by using DAPI staining and flow cytometry. Activation of caspases and Bcl-2 members was evaluated by Western blot analysis. RESULTS: A significantly increased cell death was observed in FHIT transfectants after cisplatin or paclitaxel treatment and this was attributable to the induction of apoptosis. Remarkable changes in caspases and Bcl-2 family were observed in the transfected cells as compared with the control cells after treatment with paclitaxel. Activation of caspase-3 and caspase-7 was markedly increased in cells expressing FHIT. Expression level of Bcl-2 and Bcl-xL protein was significantly decreased and that of Bax and Bad protein was significantly increased in the transfected cells. CONCLUSION: FHIT gene delivery into lung cancer cells results in enhanced apoptosis induced by treatment with cisplatin or paclitaxel. The data suggest that apoptosis in FHIT-expressing cells could be related to activation of caspase pathway and Bcl-2 family.
Apoptosis*
;
bcl-Associated Death Protein
;
bcl-X Protein
;
Blotting, Western
;
Caspase 3
;
Caspase 7
;
Caspases
;
Cell Death
;
Cell Line*
;
Cell Proliferation
;
Cisplatin
;
Flow Cytometry
;
Gene Expression
;
Histidine
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Paclitaxel
;
RNA